GB1498101A - Drugs for use in the prevention and treatment of lithiasi - Google Patents
Drugs for use in the prevention and treatment of lithiasiInfo
- Publication number
- GB1498101A GB1498101A GB799175A GB799175A GB1498101A GB 1498101 A GB1498101 A GB 1498101A GB 799175 A GB799175 A GB 799175A GB 799175 A GB799175 A GB 799175A GB 1498101 A GB1498101 A GB 1498101A
- Authority
- GB
- United Kingdom
- Prior art keywords
- drugs
- prevention
- treatment
- different
- cation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- A61K8/8117—Homopolymers or copolymers of aromatic olefines, e.g. polystyrene; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/54—Polymers characterized by specific structures/properties
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Abstract
1498101 Pharmaceutical and dentifrice compositions CENTRALA INDUSTRIALA DE MEDICAMENTE COSMETICE COLORANTI SI LACURI 26 Feb 1975 [18 July 1974] 7991/75 Heading A5B [Also in Division C3] Drugs for the prevention and treatment of lithiasis and dental tartar comprise a blend of cation exchange resin materials of sulphonic or carboxylic form, the blend containing at least four different cations. In Example, carboxylated or sulphonated styrene/divinyl benzene copolymers are treated in 4 columns in each of which a different cation is charged, and the products are then mixed and formulated into tablets, cachets or capsules with conventional binders, the different cation combinations of the Examples being as follows:- (1) H<SP>+</SP>, Na<SP>+</SP>, K<SP>+</SP>, Ca<SP>++</SP>, (2) H<SP>+</SP>, Na<SP>+</SP>, K<SP>+</SP>, Mg<SP>++</SP>, (3) H<SP>+</SP>, NH 4 <SP>+</SP>, K<SP>+</SP>, Na<SP>+</SP>, and (4) H<SP>+</SP>, Na<SP>+</SP>, K<SP>+</SP>, Mg<SP>++</SP>.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RO7952374 | 1974-07-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1498101A true GB1498101A (en) | 1978-01-18 |
Family
ID=20094004
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB799175A Expired GB1498101A (en) | 1974-07-18 | 1975-02-26 | Drugs for use in the prevention and treatment of lithiasi |
Country Status (4)
Country | Link |
---|---|
DE (1) | DE2508905C2 (en) |
ES (1) | ES435195A1 (en) |
FR (1) | FR2278342A1 (en) |
GB (1) | GB1498101A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0068453A2 (en) * | 1981-06-29 | 1983-01-05 | Adria Laboratories, Inc. | Compositions for treating kidney stones |
WO2008030512A3 (en) * | 2006-09-06 | 2008-04-24 | Genzyme Corp | Polystyrene sulfonate polymer tablets, their preparation and use |
-
1975
- 1975-02-26 GB GB799175A patent/GB1498101A/en not_active Expired
- 1975-02-27 FR FR7506097A patent/FR2278342A1/en active Granted
- 1975-02-28 ES ES435195A patent/ES435195A1/en not_active Expired
- 1975-02-28 DE DE19752508905 patent/DE2508905C2/en not_active Expired
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4395392A (en) | 1980-06-24 | 1983-07-26 | Adria Laboratories Inc. | Method for treating kidney stones |
EP0068453A2 (en) * | 1981-06-29 | 1983-01-05 | Adria Laboratories, Inc. | Compositions for treating kidney stones |
EP0068453A3 (en) * | 1981-06-29 | 1983-06-15 | Adria Laboratories, Inc. | Compositions for treating kidney stones |
WO2008030512A3 (en) * | 2006-09-06 | 2008-04-24 | Genzyme Corp | Polystyrene sulfonate polymer tablets, their preparation and use |
Also Published As
Publication number | Publication date |
---|---|
DE2508905A1 (en) | 1976-02-12 |
FR2278342B1 (en) | 1980-02-22 |
DE2508905C2 (en) | 1983-03-31 |
FR2278342A1 (en) | 1976-02-13 |
ES435195A1 (en) | 1977-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK80187A (en) | 4-aza-17-substituted-5-alpha-androstan-3-one,their a and d homo analogs,process for their preparation and pharmaceutical compositions containing them | |
GB2137616B (en) | Novel compounds | |
DE3064983D1 (en) | 2-acylaminomethyl-1,4-benzodiazepines and their salts, as well as a process for their preparation and pharmaceutical compositions containing these compounds | |
IL48704A0 (en) | Azolyl-(1)-methanes and their salts,their preparation and pharmaceutical compositions containing them | |
IL60243A (en) | Pharmaceutical compositions containing 4-heteroaroyl and aroylimidazol-2-ones,some novel compounds of this type and their preparation | |
ATE45153T1 (en) | BENZISOSELENAZOLTHIONES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL PRODUCTS CONTAINING THESE COMPOUNDS. | |
EP0289170A3 (en) | Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them | |
IL58643A (en) | Process for the preparation of 1-hydroxylated vitamin d compounds and pharmaceutical compositions comprising a 1 alpha-hydroxy-5,6-cis-bitamin d compound | |
DE2961571D1 (en) | Penicillins, their salts, process for their preparation and pharmaceutical compositions containing them | |
ATA69888A (en) | NEW SUBSTITUTED BENZAMIDES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE BENZAMIDES | |
IL81106A (en) | Antibiotic composition containing a 40926 n-acyl-aminoglucuronyl aglycon and a 40926 aglycon,process for their preparation and pharmaceutical compositions containing them | |
DE3060861D1 (en) | Monophosphonate compounds, process for their preparation and pharmaceutical compositions containing them | |
EP0229566A3 (en) | 1-benzene sulfonyl 2-oxo-5-alkoxy pyrrolidines, process for their preparation, their use as medicine and compositions containing them | |
IL52227A (en) | Process for the preparation of 10,19-dihydro-vitamin d derivatives and some novel 10,19-dihydro-1alpha-hydroxy and 1 alpha,25-dihydroxy-vitamin d3 compounds and pharmaceutical compositions containing them | |
GB1498101A (en) | Drugs for use in the prevention and treatment of lithiasi | |
DE3166731D1 (en) | Bicyclo (3,2,1) octylbenzamides, a process for their preparation and pharmaceutical compositions containing them | |
IL44266A0 (en) | Novel substituted 2-phenylamino-imidazolines-(2) and their salts,their preparation and pharmaceutical compositions containing them | |
IL47268A (en) | Racemic or optically active 4-acyl-1,3,4,5-tetrahydro-2h-1,4-benzo-diazepin-2-ones,process for their preparation and pharmaceutical compositions containing them | |
IL54111A (en) | 3,6-disubstituted-1,2,4-triazine-5-one-derivatives,process for their preparation and pharmaceutical compositions containing them | |
DE3068250D1 (en) | 3-hydroxymethyldibenzo(b,f)thiepins and dibenzo(b,f)thiepin-3-carboxaldehydes as prostaglandin antagonists, process for their preparation and pharmaceutical compositions | |
IL58576A0 (en) | 2-substituted and 2,6 disubstituted penem compounds their preparation and pharmaceutical compositions containing them | |
DE2963580D1 (en) | Beta-lactam antibacterial agents, a process for their preparation and pharmaceutical compositions containing them | |
ZA81986B (en) | Novel indane derivatives,process for their preparation,their use as pharmaceuticals and pharmaceutical compositions containing said derivatives | |
IL50399A (en) | Substituted sulphoximides,a process for their preparation and pharmaceutical compositions containing these compounds | |
FR2282419A1 (en) | SESQUITERPENIC COMPOUNDS, THEIR USE AS PERFUMING INGREDIENTS AND PROCESS FOR THE PREPARATION OF SAID COMPOUNDS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PCNP | Patent ceased through non-payment of renewal fee |